As COVID-19 Vaccine Sales Surge, BioNTech Pledges 40% Will Go To Poorer Nations

EU Adds Huge 1.8 Billion Dose Order

 
• By Andrew McConaghie

Angela Merkel consulted company’s CEO before opposing IP waiver, backing the future of Germany’s new ‘big biotech’ company.

BioNTech
BioNTech has a market cap of over $48bn, making it Europe's first true 'big biotech' company.

More from Business

More from Scrip